Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.
about
Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidatesRecombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesMucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneProtection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Live-attenuated respiratory syncytial virus vaccines.Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.Respiratory syncytial virus vaccine: Is it coming?Modeling the structure of the respiratory syncytial virus small hydrophobic protein by silent-mutation analysis of global searching molecular dynamics.
P2860
Q27469676-1C8F12AF-2D62-4016-8E17-8C56A5F32CE9Q33605207-2957F90C-1841-483C-95E5-412BD54642C8Q34328895-EA5B6753-FE3C-4FEA-BECD-C2E48FE74138Q34542687-D19C477D-CDAD-413E-8115-6740C7EDC7E6Q34717853-2ABB94A7-3C26-4B2F-85AC-A3DEB4EF02CCQ36237057-7CF81682-1DDF-4327-AE5E-02A8C51AC762Q36692801-A907BC43-D57D-491A-AF58-3B95617504FBQ37348134-25F04CD6-FD6A-46E1-BAB2-11A4059CBB9DQ37481336-019B1BAD-4B19-416D-B91D-DA066DE8B026Q43205497-001CB6D9-5BB0-4D87-A1B4-26236FC1F14C
P2860
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Replacement of the F and G pro ...... subgroup B vaccine candidates
@nl
Replacement of the F and G pro ...... subgroup B vaccine candidates.
@ast
Replacement of the F and G pro ...... subgroup B vaccine candidates.
@en
type
label
Replacement of the F and G pro ...... subgroup B vaccine candidates
@nl
Replacement of the F and G pro ...... subgroup B vaccine candidates.
@ast
Replacement of the F and G pro ...... subgroup B vaccine candidates.
@en
prefLabel
Replacement of the F and G pro ...... subgroup B vaccine candidates
@nl
Replacement of the F and G pro ...... subgroup B vaccine candidates.
@ast
Replacement of the F and G pro ...... subgroup B vaccine candidates.
@en
P2093
P2860
P1433
P1476
Replacement of the F and G pro ...... subgroup B vaccine candidates
@en
P2093
B R Murphy
C Y Firestone
M St Claire
P L Collins
S S Whitehead
W R Elkins
P2860
P304
P577
1999-12-01T00:00:00Z